Follow
Dipti Tillu, DV Tillu
Dipti Tillu, DV Tillu
University of Arizona, University of Iowa, University of Texas at Dallas
Verified email at email.arizona.edu
Title
Cited by
Cited by
Year
Targeting adenosine monophosphate-activated protein kinase (AMPK) in preclinical models reveals a potential mechanism for the treatment of neuropathic pain
OK Melemedjian, MN Asiedu, DV Tillu, R Sanoja, J Yan, A Lark, ...
Molecular pain 7, 1744-8069-7-70, 2011
2242011
IL-6-and NGF-induced rapid control of protein synthesis and nociceptive plasticity via convergent signaling to the eIF4F complex
OK Melemedjian, MN Asiedu, DV Tillu, KA Peebles, J Yan, N Ertz, ...
Journal of Neuroscience 30 (45), 15113-15123, 2010
2182010
Resveratrol engages AMPK to attenuate ERK and mTOR signaling in sensory neurons and inhibits incision-induced acute and chronic pain
DV Tillu, OK Melemedjian, MN Asiedu, N Qu, M De Felice, G Dussor, ...
Molecular Pain 8, 1744-8069-8-5, 2012
1882012
Spinal protein kinase M ζ underlies the maintenance mechanism of persistent nociceptive sensitization
MN Asiedu, DV Tillu, OK Melemedjian, A Shy, R Sanoja, B Bodell, ...
Journal of Neuroscience 31 (18), 6646-6653, 2011
1522011
Descending facilitatory pathways from the RVM initiate and maintain bilateral hyperalgesia after muscle insult
DV Tillu, GF Gebhart, KA Sluka
Pain 136 (3), 331-339, 2008
1312008
BDNF regulates atypical PKC at spinal synapses to initiate and maintain a centralized chronic pain state
OK Melemedjian, DV Tillu, MN Asiedu, EK Mandell, JK Moy, VM Blute, ...
Molecular pain 9, 1744-8069-9-12, 2013
992013
Local translation and retrograde axonal transport of CREB regulates IL-6-induced nociceptive plasticity
OK Melemedjian, DV Tillu, JK Moy, MN Asiedu, EK Mandell, S Ghosh, ...
Molecular pain 10, 1744-8069-10-45, 2014
932014
Spinal dopaminergic projections control the transition to pathological pain plasticity via a D1/D5-mediated mechanism
JYV Kim, DV Tillu, TL Quinn, GL Mejia, A Shy, MNK Asiedu, E Murad, ...
Journal of Neuroscience 35 (16), 6307-6317, 2015
812015
Protease-activated receptor 2 activation is sufficient to induce the transition to a chronic pain state
DV Tillu, SN Hassler, CC Burgos-Vega, TL Quinn, RE Sorge, G Dussor, ...
Pain 156 (5), 859-867, 2015
702015
Extracellular phosphorylation of a receptor tyrosine kinase controls synaptic localization of NMDA receptors and regulates pathological pain
K Hanamura, HR Washburn, SI Sheffler-Collins, NL Xia, N Henderson, ...
PLoS biology 15 (7), e2002457, 2017
612017
Pharmacological activation of AMPK inhibits incision-evoked mechanical hypersensitivity and the development of hyperalgesic priming in mice
MD Burton, DV Tillu, K Mazhar, GL Mejia, MN Asiedu, K Inyang, T Hughes, ...
Neuroscience 359, 119-129, 2017
542017
The novel PAR2 ligand C391 blocks multiple PAR2 signalling pathways in vitro and in vivo
S Boitano, J Hoffman, AN Flynn, MN Asiedu, DV Tillu, Z Zhang, ...
British journal of pharmacology 172 (18), 4535-4545, 2015
502015
The protease-activated receptor-2-specific agonists 2-aminothiazol-4-yl-LIGRL-NH2 and 6-aminonicotinyl-LIGRL-NH2 stimulate multiple signaling pathways to induce physiological …
AN Flynn, DV Tillu, MN Asiedu, J Hoffman, J Vagner, TJ Price, S Boitano
Journal of Biological Chemistry 286 (21), 19076-19088, 2011
372011
Development of highly potent protease-activated receptor 2 agonists via synthetic lipid tethering
AN Flynn, J Hoffman, DV Tillu, CL Sherwood, Z Zhang, R Patek, ...
The FASEB Journal 27 (4), 1498, 2013
362013
Temporal and sex differences in the role of BDNF/TrkB signaling in hyperalgesic priming in mice and rats
JK Moy, T Szabo-Pardi, DV Tillu, S Megat, G Pradhan, M Kume, ...
Neurobiology of Pain 5, 100024, 2019
342019
Meningeal norepinephrine produces headache behaviors in rats via actions both on dural afferents and fibroblasts
X Wei, J Yan, D Tillu, M Asiedu, N Weinstein, O Melemedjian, T Price, ...
Cephalalgia 35 (12), 1054-1064, 2015
272015
Development and Evaluation of Small Peptidomimetic Ligands to Protease-Activated Receptor-2 (PAR2) through the Use of Lipid Tethering
S Boitano, J Hoffman, DV Tillu, MN Asiedu, Z Zhang, CL Sherwood, ...
PLoS One 9 (6), e99140, 2014
232014
Lanthanide labeling of a potent protease activated receptor-2 agonist for time-resolved fluorescence analysis
J Hoffman, AN Flynn, DV Tillu, Z Zhang, R Patek, TJ Price, J Vagner, ...
Bioconjugate chemistry 23 (10), 2098-2104, 2012
202012
Correction: Extracellular phosphorylation of a receptor tyrosine kinase controls synaptic localization of NMDA receptors and regulates pathological pain
K Hanamura, HR Washburn, SI Sheffler-Collins, NL Xia, N Henderson, ...
Plos Biology 19 (11), e3001452, 2021
12021
Methods and compositions using ampk activators for pharmacological prevention of chronic pain
TJ Price, G Dussor, D Tillu, B Lian
US Patent App. 16/029,219, 2018
12018
The system can't perform the operation now. Try again later.
Articles 1–20